First Time Loading...

Conmed Corp
NYSE:CNMD

Watchlist Manager
Conmed Corp Logo
Conmed Corp
NYSE:CNMD
Watchlist
Price: 71.08 USD -2.31% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. [ Read More ]

The intrinsic value of one CNMD stock under the Base Case scenario is 148.79 USD. Compared to the current market price of 71.08 USD, Conmed Corp is Undervalued by 52%.

Key Points:
CNMD Intrinsic Value
Base Case
148.79 USD
Undervaluation 52%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Conmed Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CNMD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Conmed Corp

Provide an overview of the primary business activities
of Conmed Corp.

What unique competitive advantages
does Conmed Corp hold over its rivals?

What risks and challenges
does Conmed Corp face in the near future?

Has there been any significant insider trading activity
in Conmed Corp recently?

Summarize the latest earnings call
of Conmed Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Conmed Corp.

Provide P/S
for Conmed Corp.

Provide P/E
for Conmed Corp.

Provide P/OCF
for Conmed Corp.

Provide P/FCFE
for Conmed Corp.

Provide P/B
for Conmed Corp.

Provide EV/S
for Conmed Corp.

Provide EV/GP
for Conmed Corp.

Provide EV/EBITDA
for Conmed Corp.

Provide EV/EBIT
for Conmed Corp.

Provide EV/OCF
for Conmed Corp.

Provide EV/FCFF
for Conmed Corp.

Provide EV/IC
for Conmed Corp.

Show me price targets
for Conmed Corp made by professional analysts.

What are the Revenue projections
for Conmed Corp?

How accurate were the past Revenue estimates
for Conmed Corp?

What are the Net Income projections
for Conmed Corp?

How accurate were the past Net Income estimates
for Conmed Corp?

What are the EPS projections
for Conmed Corp?

How accurate were the past EPS estimates
for Conmed Corp?

What are the EBIT projections
for Conmed Corp?

How accurate were the past EBIT estimates
for Conmed Corp?

Compare the revenue forecasts
for Conmed Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Conmed Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Conmed Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Conmed Corp compared to its peers.

Compare the P/E ratios
of Conmed Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Conmed Corp with its peers.

Analyze the financial leverage
of Conmed Corp compared to its main competitors.

Show all profitability ratios
for Conmed Corp.

Provide ROE
for Conmed Corp.

Provide ROA
for Conmed Corp.

Provide ROIC
for Conmed Corp.

Provide ROCE
for Conmed Corp.

Provide Gross Margin
for Conmed Corp.

Provide Operating Margin
for Conmed Corp.

Provide Net Margin
for Conmed Corp.

Provide FCF Margin
for Conmed Corp.

Show all solvency ratios
for Conmed Corp.

Provide D/E Ratio
for Conmed Corp.

Provide D/A Ratio
for Conmed Corp.

Provide Interest Coverage Ratio
for Conmed Corp.

Provide Altman Z-Score Ratio
for Conmed Corp.

Provide Quick Ratio
for Conmed Corp.

Provide Current Ratio
for Conmed Corp.

Provide Cash Ratio
for Conmed Corp.

What is the historical Revenue growth
over the last 5 years for Conmed Corp?

What is the historical Net Income growth
over the last 5 years for Conmed Corp?

What is the current Free Cash Flow
of Conmed Corp?

Financials

Balance Sheet Decomposition
Conmed Corp

Current Assets 615.6m
Cash & Short-Term Investments 24.3m
Receivables 242.3m
Other Current Assets 349.1m
Non-Current Assets 1.7B
PP&E 120.7m
Intangibles 1.5B
Other Non-Current Assets 107.3m
Current Liabilities 310.7m
Accounts Payable 88.2m
Accrued Liabilities 70.1m
Other Current Liabilities 152.4m
Non-Current Liabilities 1.2B
Long-Term Debt 973.1m
Other Non-Current Liabilities 181.9m
Efficiency

Earnings Waterfall
Conmed Corp

Revenue
1.2B USD
Cost of Revenue
-568.5m USD
Gross Profit
676.2m USD
Operating Expenses
-554.8m USD
Operating Income
121.4m USD
Other Expenses
-56.9m USD
Net Income
64.5m USD

Free Cash Flow Analysis
Conmed Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

CNMD Profitability Score
Profitability Due Diligence

Conmed Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Free Cash Flow
ROE is Increasing
51/100
Profitability
Score

Conmed Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

CNMD Solvency Score
Solvency Due Diligence

Conmed Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
Average D/E
38/100
Solvency
Score

Conmed Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CNMD Price Targets Summary
Conmed Corp

Wall Street analysts forecast CNMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNMD is 112.78 USD with a low forecast of 98.98 USD and a high forecast of 138.6 USD.

Lowest
Price Target
98.98 USD
39% Upside
Average
Price Target
112.78 USD
59% Upside
Highest
Price Target
138.6 USD
95% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CNMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CNMD Price
Conmed Corp

1M 1M
-7%
6M 6M
-24%
1Y 1Y
-38%
3Y 3Y
-44%
5Y 5Y
-7%
10Y 10Y
+69%
Annual Price Range
71.08
52w Low
71.08
52w High
136.38
Price Metrics
Average Annual Return 9.09%
Standard Deviation of Annual Returns 35.78%
Max Drawdown -66%
Shares Statistics
Market Capitalization 2.2B USD
Shares Outstanding 30 791 200
Percentage of Shares Shorted 18.32%

CNMD Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Conmed Corp Logo
Conmed Corp

Country

United States of America

Industry

Health Care

Market Cap

2.2B USD

Dividend Yield

1.1%

Description

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. The company is headquartered in Largo, Florida and currently employs 3,800 full-time employees. The firm's products consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including dissociated two horizontal deviation and three horizontal deviation vision technologies. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. Its products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.

Contact

FLORIDA
Largo
11311 Concept Boulevard
+17272142974.0
https://www.conmed.com/

IPO

1987-07-23

Employees

3 800

Officers

Chairman of the Board, CEO & President
Mr. Curt R. Hartman
Executive VP & CFO
Mr. Todd W. Garner
Executive VP and Chief Human Resources & Legal Officer
Ms. Heather L. Cohen
President of International & Global Orthopedics
Mr. Patrick J. Beyer
President of Advanced Surgical & Advanced Endoscopic Technologies
Mr. Stanley W. Peters III
Executive Vice President of Strategy & Corporate Development
Mr. Peter K. Shagory
Show More
Executive VP of Information Technology & CIO
Ms. Shanna L. Cotti-Osmanski
Executive Vice President of Human Resources
Mr. John Ferrell
Special Counsel & Corporate Secretary
Mr. Daniel S. Jonas Esq.
President of ConMed Electrosurgery
Mr. David R. Murray
Show Less

See Also

Discover More
What is the Intrinsic Value of one CNMD stock?

The intrinsic value of one CNMD stock under the Base Case scenario is 148.79 USD.

Is CNMD stock undervalued or overvalued?

Compared to the current market price of 71.08 USD, Conmed Corp is Undervalued by 52%.